The rs2004640 single nucleotide polymorphism and the CGGGG copy-number variant (rs77571059) are promoter polymorphisms within interferon regulatory factor 5 (IRF5). They have been implicated as susceptibility factors for several autoimmune diseases. IRF5 uses alternative promoter splicing, where any of 4 first exons begin the mRNA. The CGGGG indel is in exon 1A's promoter; the rs2004640 allele creates a splicing recognition site, enabling usage of exon 1B. This study aimed at characterizing alterations in IRF5 mRNA due to these polymorphisms. Cells with risk polymorphisms exhibited ∼2-fold higher levels of IRF5 mRNA and protein, but demonstrated no change in mRNA stability. Quantitative PCR demonstrated decreased usage of exons 1C and 1D in cell lines with the risk polymorphisms. RNA folding analysis revealed a hairpin in exon 1B; mutational analysis showed that the hairpin shape decreased translation 5-fold. Although translation of mRNA that uses exon 1B is low due to a hairpin, increased IRF5 mRNA levels in individuals with the rs2004640 risk allele lead to higher overall protein expression. In addition, several new splice variants of IRF5 were sequenced. IRF5's promoter polymorphisms alter first exon usage and increase transcription levels. High levels of IRF5 may bias the immune system toward autoimmunity.
Get full access to this article
View all access options for this article.
References
1.
AgarwalSK. 2010. The genetics of systemic sclerosis. Discov Med, 10(51):134–143.
2.
Alonso-PerezE, Suarez-GestalM, CalazaM, KwanT, MajewskiJ, Gomez-ReinoJJ, GonzalezA. 2011. Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines. Arthritis Res Ther, 13(3):R80.
3.
BalkhiMY, FitzgeraldKA, PithaPM. 2010. IKKα negatively regulates IRF-5 function in a MyD88–TRAF6 pathway. Cell Signal, 22(1):117–127.
4.
BarnesBJ, KellumMJ, FieldAE, PithaPM. 2002. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol, 22(16):5721–5740.
5.
BarnesBJ, KellumMJ, PinderKE, FrisanchoJA, PithaPM. 2003. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res, 63(19):6424–6431.
Cahir-McFarlandED, CarterK, RosenwaldA, GiltnaneJM, HenricksonSE, StaudtLM, KieffE. 2004. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol, 78(8):4108–4119.
8.
DidebergV, KristjansdottirG, MilaniL, LibioulleC, SigurdssonS, LouisE, WimanAC, VermeireS, RutgeertsP, BelaicheJ, FranchimontD, Van GossumA, BoursV, SyvanenAC. 2007. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet, 16(24):3008–3016.
9.
Dieguez-GonzalezR, CalazaM, Perez-PampinE, de la SernaAR, Fernandez-GutierrezB, CastanedaS, LargoR, JovenB, NarvaezJ, NavarroF, MarencoJL, VicarioJL, BlancoFJ, Fernandez-LopezJC, CalizR, Collado-EscobarMD, CarrenoL, Lopez-LongoJ, CaneteJD, Gomez-ReinoJJ, GonzalezA. 2008. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum, 58(5):1264–1274.
10.
DieudeP, GuedjM, WipffJ, AvouacJ, FajardyI, DiotE, GranelB, SibiliaJ, CabaneJ, MouthonL, CracowskiJL, CarpentierPH, HachullaE, MeyerO, KahanA, BoileauC, AllanoreY. 2009. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis. Arthritis Rheum, 60(1):225–233.
11.
EmilieD, LlorenteL, GalanaudP. 1996. Cytokines and systemic lupus erythematosus. Ann Med Interne, 147(7):480–484.
12.
FanJH, GaoLB, PanXM, LiC, LiangWB, LiuJ, LiY, ZhangL. 2010. Association between IRF-5 polymorphisms and risk of acute coronary syndrome. DNA Cell Biol, 29(1):19–23.
13.
FengD, StoneRC, ElorantaM-L, Sangster-GuityN, NordmarkG, SigurdssonS, WangC, AlmG, SyvänenA-C, RönnblomL, BarnesBJ. 2010. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum, 62(2):562–573.
14.
GrahamRR, KozyrevSV, BaechlerEC, ReddyMV, PlengeRM, BauerJW, OrtmannWA, KoeuthT, Gonzalez EscribanoMF, Pons-EstelB, PetriM, DalyM, GregersenPK, MartinJ, AltshulerD, BehrensTW, Alarcon-RiquelmeME. 2006. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet, 38(5):550–555.
15.
GrahamRR, KyogokuC, SigurdssonS, VlasovaIA, DaviesLRL, BaechlerEC, PlengeRM, KoeuthT, OrtmannWA, HomG, BauerJW, GillettC, BurttN, GrahamDSC, OnofrioR, PetriM, GunnarssonI, SvenungssonE, RonnblomL, NordmarkG, GregersenPK, MoserK, GaffneyPM, CriswellLA, VyseTJ, SyvanenAC, BohjanenPR, DalyMJ, BehrensTW, AltshulerD. 2007. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A, 104(16):6758–6763.
16.
GrievinkH, StowellK. 2010. Allele-specific differences in ryanodine receptor 1 mRNA expression levels may contribute to phenotypic variability in malignant hyperthermia. Orphanet J Rare Dis, 5(1):10
17.
HedlM, AbrahamC. 2012. IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells. J Immunol, 188(11):5348–5356.
18.
HuG, BarnesBJ. 2009. IRF-5 Is a mediator of the death receptor-induced apoptotic signaling pathway. J Biol Chem, 284(5):2767–2777.
19.
HuG, ManclME, BarnesBJ. 2005. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res, 65(16):7403–7412.
20.
KaplanMJ. 2004. Apoptosis in systemic lupus erythematosus. Clin Immunol, 112(3):210–218.
21.
KawasakiA, KyogokuC, OhashiJ, MiyashitaR, HikamiK, KusaoiM, TokunagaK, TakasakiY, HashimotoH, BehrensTW, TsuchiyaN. 2008. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum, 58(3):826–834.
KimYJ, ParkJH, KimI, KimJO, BaeJS, ShinHD, BaeSC. 2008. Putative role of functional interferon regulatory factor 5 (IRF5) polymorphism in rheumatoid arthritis in a Korean population. J Rheumatol, 35(11):2106–2118.
24.
KozakM. 1999. Initiation of translation in prokaryotes and eukaryotes. Gene, 234(2):187–208.
25.
KozyrevSV, LewenS, ReddyPM, Pons-EstelB, WitteT, JunkerP, LaustrupH, GutierrezC, SuarezA, Francisca Gonzalez-EscribanoM, MartinJ, Alarcon-RiquelmeME. 2007. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum, 56(4):1234–1241.
KristjansdottirG, SandlingJK, BonettiA, RoosIM, MilaniL, WangC, GustafsdottirSM, SigurdssonS, LundmarkA, TienariPJ, KoivistoK, ElovaaraI, PirttilaT, ReunanenM, PeltonenL, SaarelaJ, HillertJ, OlssonT, LandegrenU, AlcinaA, FernandezO, LeyvaL, GuerreroM, LucasM, IzquierdoG, MatesanzF, SyvanenAC. 2008. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet, 45(6):362–369.
28.
LienCY, FangCM, HusoD, LivakF, LuRQ, PithaPM. 2010. Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A, 107(10):4664–4668.
29.
LinR, YangL, ArguelloM, PenafuerteC, HiscottJ. 2005. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J Biol Chem, 280(4):3088–3095.
30.
LiuHF, AnXJ, YangY, YangL, LiY, HuangCZ, TaoJ, TuYT. 2013. Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: a meta-analysis. J Huazhong Univ Sci Technolog Med Sci, 33(1):15–21.
31.
LondinER, KellerMA, D'AndreaMR, DelgrossoK, ErtelA, SurreyS, FortinaP. 2011. Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor. BMC Genomics, 12:464
32.
ManclME, HuG, Sangster-GuityN, OlshalskySL, HoopsK, Fitzgerald-BocarslyP, PithaPM, PinderK, BarnesBJ. 2005. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem, 280(22):21078–21090.
33.
MartinHJ, LeeJM, WallsD, HaywardSD. 2007. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol, 81(18):9748–9758.
34.
MellorJ. 2005. The dynamics of chromatin remodeling at promoters. Mol Cell, 19(2):147–157.
35.
Miceli-RichardC, CometsE, LoiseauP, PuechalX, HachullaE, MarietteX. 2007. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum, 56(12):3989–3994.
NiewoldTB, KellyJA, FleschMH, EspinozaLR, HarleyJB, CrowMK. 2008. Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients. Arthritis Rheum, 58(8):2481–2487.
38.
NiewoldTB, KellyJA, KariukiSN, FranekBS, KumarAA, KaufmanKM, ThomasK, WalkerD, KampS, FrostJM, WongAK, MerrillJT, Alarcón-RiquelmeME, TiklyM, Ramsey-GoldmanR, ReveilleJD, PetriMA, EdbergJC, KimberlyRP, AlarcónGS, KamenDL, GilkesonGS, VyseTJ, JamesJA, GaffneyPM, MoserKL, CrowMK, HarleyJB. 2012. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis, 71(3):463–469.
39.
NordangGBN, VikenMK, AmundsenSS, SanchezES, FlatøB, FørreØT, MartinJ, KvienTK, LieBA. 2012. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts. Rheumatology, 51(4):619–626.
40.
NordmarkG, KristjansdottirG, TheanderE, ErikssonP, BrunJG, WangC, PadyukovL, TruedssonL, AlmG, ElorantaML, JonssonR, RonnblomL, SyvanenAC. 2008. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. Genes Immun, 10(1):68–76.
41.
QinL, LvJ, ZhouX, HouP, YangH, ZhangH. 2010. Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology (Carlton), 15(7):710–713.
42.
RulloOJ, WooJMP, WuH, HoftmanADC, MaranianP, BrahnBA, McCurdyD, CantorR, TsaoB. 2010. Association of IRF5 polymorphisms with activation of the Interferon-alpha pathway. Ann Rheum Dis, 69:611–617.
43.
SavitskyDA, YanaiH, TamuraT, TaniguchiT, HondaK. 2010. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci U S A, 107(22):10154–10159.
44.
ShinSH, KimB-h, JangJ-J, SuhKS, KangGH. 2010. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. J Korean Med Sci, 25(8):1152–1159.
SigurdssonS, GöringHHH, KristjansdottirG, MilaniL, NordmarkG, SandlingJK, ElorantaM-L, FengD, Sangster-GuityN, GunnarssonI, SvenungssonE, SturfeltG, JönsenA, TruedssonL, BarnesBJ, AlmG, RönnblomL, SyvänenA-C. 2008. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet, 17(6):872–881.
47.
SigurdssonS, NordmarkG, GoringHH, LindroosK, WimanAC, SturfeltG, JonsenA, Rantapaa-DahlqvistS, MollerB, KereJ, KoskenmiesS, WidenE, ElorantaML, JulkunenH, KristjansdottirH, SteinssonK, AlmG, RonnblomL, SyvanenAC. 2005. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet, 76(3):528–537.
48.
SigurdssonS, PadyukovL, KurreemanFA, LiljedahlU, WimanAC, AlfredssonL, ToesR, RonnelidJ, KlareskogL, HuizingaTW, AlmG, SyvanenAC, RonnblomL. 2007. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum, 56(7):2202–2210.
49.
SuAI, WiltshireT, BatalovS, LappH, ChingKA, BlockD, ZhangJ, SodenR, HayakawaM, KreimanG, CookeMP, WalkerJR, HogeneschJB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A, 101(16):6062–6067.
50.
TadaY, KondoS, AokiS, KoaradaS, InoueH, SuematsuR, OhtaA, MakTW, NagasawaK. 2011. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum, 63(3):738–748.
TsuchiyaN, ItoI, KawasakiA. 2010. Association of IRF5, STAT4 and BLK with systemic lupus erythematosus and other rheumatic diseases. Nihon Rinsho Meneki Gakkai Kaishi, 33(2):57–65.
53.
ValouevA, JohnsonSM, BoydSD, SmithCL, FireAZ, SidowA. 2011. Determinants of nucleosome organization in primary human cells. Nature, 474(7352):516–520.
54.
VosslamberS, van der VoortLF, van den ElskampIJ, HeijmansR, AubinC, UitdehaagBM, CrusiusJB, van der PouwKraanTC, ComabellaM, MontalbanX, HaflerDA, De JagerPL, KillesteinJ, PolmanCH, VerweijCL. 2011. Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonbeta therapy in multiple sclerosis. Genes Immun, 12(6):466–472.
55.
XuY, LeePY, LiY, LiuC, ZhuangH, HanS, NacionalesDC, WeinsteinJ, MathewsCE, MoldawerLL, LiSW, SatohM, YangLJ, ReevesWH. 2012. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus. J Immunol, 188(8):4113–4121.
56.
YamashitaM, ToyotaM, SuzukiH, NojimaM, YamamotoE, KamimaeS, WatanabeY, KaiM, AkashiH, MaruyamaR, SasakiY, YamanoH, SugaiT, ShinomuraY, ImaiK, TokinoT, ItohF. 2010. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci, 101(7):1708–1716.
57.
YanagimachiM, NarutoT, MiyamaeT, HaraT, KikuchiM, HaraR, ImagawaT, MoriM, SatoH, GotoH, YokotaS. 2011. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol., 38(4):769–774.
58.
YanaiH, ChenHM, InuzukaT, KondoS, MakTW, TakaokaA, HondaK, TaniguchiT. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci U S A, 104(9):3402–3407.
59.
YangL, FengD, BiX, StoneRC, BarnesBJ. 2012. Monocytes from Irf5−/− mice have an intrinsic defect in their response to pristane-induced lupus. J Immunol, 189(7):3741–3750.
60.
ZukerM. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res, 31(13):3406–3415.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
